Savvy Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Savvy Advisors's VIR Position: Q3 2026 in Review
Savvy Advisors reduced its Vir Biotechnology (VIR) stake by 20% in Q3 2026, selling an estimated $2.03M and leaving 837,570 shares worth $9.36M. The position accounts for 0.16% of the portfolio, ranked #114.
Savvy Advisors first reported a position in VIR in Q2 2026 and has held it in 2 quarters since. The position peaked at $10.6M in Q2 2026. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Savvy Advisors held 837,570 shares of Vir Biotechnology worth $9.36M as of Q3 2026.
- Savvy Advisors sold 203,095 Vir Biotechnology shares in Q3 2026, an estimated $2.03M.
- Vir Biotechnology made up 0.16% of Savvy Advisors's portfolio in Q3 2026, its #114 holding.
- Savvy Advisors first reported a position in Vir Biotechnology in Q2 2026 and has held it in 2 quarters since.
- Savvy Advisors's Vir Biotechnology position peaked at $10.6M in Q2 2026.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Savvy Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.